Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Phase II Study on Venetoclax (Ven) Plus Decitabine (Dec) (Ven-Dec) for Elderly (≥60 <75years) Patients with Newly Diagnosed High-Intermediate Risk Acute Myeloid Leukemia (AML) Elegible for Allogeneic Stem Cell Transplantation: Final Report of Ven DEC GITMO Study

Blood (2023) 142 (Supplement 1): 1513.

https://doi.org/10.1182/blood-2023-185045

Published: 2023

Journal Articles

Clarithromycin Enhances tyrosine Kinase Inhibitor – Induced Cell Death by Inhibition of Late Stage Autophagy in Patients with Chronic Myeloid Leukemia At Diagnosis or with Resistant Stage of Disease

A. M. Carella, MD, G. Beltrami, MD, G. Pica, MD, C. Ghiggi, MD, D. Lovera, MD, G. Cirmena, A. Garuti

Blood (2012) 120 (21): 3777.

https://doi.org/10.1182/blood.V120.21.3777.3777

Published: 2012

Journal Articles

Minimal Residual Disease After the First Cycle of Chemotherapy in Acute Myeloid Leukemia: A Comparative Study of WT1 RQ-PCR and 4-Color Flow Cytometry.

Carlo Marani, MD, Raffaella Grasso, PhD, Nicoletta Colombo, Marino Clavio, MD, Fabio Guolo, MD, Annalisa Kunkl, Livia Giannoni, MD, Giuseppina Fugazza, PhD, Roberto Bruzzone, Mario Sessarego, MD, A. M. Carella, MD, Marco Gobbi, MD, Maurizio Miglino, PhD

Blood (2012) 120 (21): 2535.

https://doi.org/10.1182/blood.V120.21.2535.2535

Published: 2012

Journal Articles

A Phase I Study of Hypofractionated Tailored Total Marrow or Total Lymphoid Irradiation with Helical Tomotherapy Plus Chemotherapy As a Conditioning Regimen for Autologous Stem Cell Transplantation

G. Pica, S. Vagge, G. Beltrami, S. Nati, G. Catania, R. Corvò, A. M. Carella, MD

Blood (2011) 118 (21): 4523.

https://doi.org/10.1182/blood.V118.21.4523.4523

Published: 2011

Journal Articles

GeneXpert Essay for BCR-ABL Compared to RT-PCR for Clinical Management of CML

G. Pica, G. Catania, F. Castelli, C Repetto, A. M. Carella, MD, M. Mussap

Blood (2011) 118 (21): 4416.

https://doi.org/10.1182/blood.V118.21.4416.4416

Published: 2011

Journal Articles

Clarithromycin Targeting Autophagy Potentiates Tyrosine Kinase Inhibitor-Induced Cell Death in Resistant Chronic Myeloid Leukemia (CML) Patients

A. M. Carella, MD, Gioacchino Catania, MD, G. Beltrami, G. Pica

Blood (2011) 118 (21): 4450.

https://doi.org/10.1182/blood.V118.21.4450.4450

Published: 2011

Journal Articles

Safety and Efficacy of 90Y Ibritumomab Tiuxetan (Zevalin®) for Untreated FollicularNon-Hodgkin's Lymphoma (FL) Patients, An Italian Cooperative Study

G. Pica, S. Nati, Umberto Vitolo, MD, Sara Galimberti, Pier Luigi Zinzani, MD, PhD, Nicola Cascavilla, Mario Petrini, MD, A. M. Carella, MD

Blood (2011) 118 (21): 100.

https://doi.org/10.1182/blood.V118.21.100.100

Published: 2011

Journal Articles

Long Term Follow-up of Ph+ CML Patients Achieving Complete Cytogenetic Response (CCgR) with Interferon Based Therapy - GIMEMA Protocol CML0509

Domenico Russo, Giuliana Alimena, Chiara Colombi, Massimo Breccia, Simona Soverini, Ilaria Iacobucci, PhD, Federica Cattina, MD, Giovanni Martinelli, MD, Nicoletta Testoni, Anna Marina Liberati, Viviana Appolloni, Mario Tiribelli, Renato Fanin, Felicetto Ferrara, MD, Mario Annunziata, MD, Elena Trabacchi, Daniele Vallisa, MD, Antonio De Vivo, Fausto Castagnetti, Miriam Fogli, Sandra Durante, Francesco Di Raimondo, MD, Fabio Stagno, A. M. Carella, G. Pica, Alessandra Iurlo, M.D., Tommaso Radice, Patrizia Pregno, MD, Umberto Vitolo, MD, Elisabetta Abruzzese, Paolo de Fabritiis, Maurizio Longinotti, MD, Simonetta Pardini, Caterina Musolino, MD, Sabina Russo, Marco Gobbi, MD, Ivana Pierri, Gianluca Gaidano, Monia Lunghi, M.D., Giuseppe Visani, Sara Barulli, Mario Cazzola, Serena Merante, Cristina Skert, MD, Michele Malagola, Gianantonio Rosti, MD, Michele Baccarani, MD

Blood (2011) 118 (21): 786.

https://doi.org/10.1182/blood.V118.21.786.786

Published: 2011

Journal Articles

Sustained Complete Molecular Response (CMR) with Interferon-alpha Maintenance After Induction with Imatinib In Chronic Myeloid Leukemia (CML) Patients.

A. M. Carella, G. Catania, G. Pica and G. Beltrami

Blood (2010) 116 (21): 4486.

https://doi.org/10.1182/blood.V116.21.4486.4486

Published: 2010

Journal Articles

ABL Mutations In Early Chronic Phase Chronic Myeloid Leukemia (CP-CML) Are Associated with a Greater Likelihood of Progression and Shorter Survival

A. M. Carella, A. Garuti, G. Cirmena, G. Catania, G. Pica, G. Beltrami, F. Patrone

Blood (2010) 116 (21): 4458.

https://doi.org/10.1182/blood.V116.21.4458.4458

Published: 2010

Journal Articles

Adult Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph + ALL) Treated at Diagnosis with Imatinib Followed by 2 nd Line TKI (Imatinib or Dasatinib) and Stem Cell Transplantation.

A. M. Carella, G. Catania, G. Pica, G. Beltrami, S. Nati, R. Vimercati, A. Congiu, E. Rossi, M. Spriano

Blood (2009) 114 (22): 4109.

https://doi.org/10.1182/blood.V114.22.4109.4109

Published: 2009

Journal Articles

90 y Ibritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group

A. M. Carella, S. Nati, G. Fraternali Orcioni, M. Petrini, S. Galimberti, U. Vitolo, N. Cascavilla, P.L. Zinzani

Blood (2008) 112 (11): 3061.

https://doi.org/10.1182/blood.V112.11.3061.3061

Published: 2008

Journal Articles

Reduced-Intensity Conditioning for Allograft (RICT) after Cytoreductive Autograft (ASCT) in Relapsed/Resistant Hodgkin’s Lymphoma (HL)

A. M. Carella, E. Todisco, L. Castagna, A. Santoro, G. Catania, S Nati, A Congiu, R Vimercati, E Rossi, M Spriano, R Varaldo

Blood (2008) 112 (11): 3294.

https://doi.org/10.1182/blood.V112.11.3294.3294

Published: 2008

Journal Articles

Late Platelets Recovery after Autografting (ASCT) in Patients with Acute Myeloid Leukemia (AML) Is A Prognostically Favourable Factor for Long-Term Remission

A. M. Carella, G Catania, R Varaldo, S Nati, A Congiu, R Vimercati, E Rossi, M Spriano

Blood (2008) 112 (11): 4433.

https://doi.org/10.1182/blood.V112.11.4433.4433

Published: 2008

NARROW

Phase II Study on Venetoclax (Ven) Plus Decitabine (Dec) (Ven-Dec) for Elderly (≥60 <75years) Patients with Newly Diagnosed High-Intermediate Risk Acute Myeloid Leukemia (AML) Elegible for Allogeneic Stem Cell Transplantation: Final Report of Ven DEC GITMO Study

Clarithromycin Enhances tyrosine Kinase Inhibitor – Induced Cell Death by Inhibition of Late Stage Autophagy in Patients with Chronic Myeloid Leukemia At Diagnosis or with Resistant Stage of Disease

Minimal Residual Disease After the First Cycle of Chemotherapy in Acute Myeloid Leukemia: A Comparative Study of WT1 RQ-PCR and 4-Color Flow Cytometry.

A Phase I Study of Hypofractionated Tailored Total Marrow or Total Lymphoid Irradiation with Helical Tomotherapy Plus Chemotherapy As a Conditioning Regimen for Autologous Stem Cell Transplantation

GeneXpert Essay for BCR-ABL Compared to RT-PCR for Clinical Management of CML

Clarithromycin Targeting Autophagy Potentiates Tyrosine Kinase Inhibitor-Induced Cell Death in Resistant Chronic Myeloid Leukemia (CML) Patients

Safety and Efficacy of 90Y Ibritumomab Tiuxetan (Zevalin®) for Untreated FollicularNon-Hodgkin's Lymphoma (FL) Patients, An Italian Cooperative Study

Long Term Follow-up of Ph+ CML Patients Achieving Complete Cytogenetic Response (CCgR) with Interferon Based Therapy - GIMEMA Protocol CML0509

Sustained Complete Molecular Response (CMR) with Interferon-alpha Maintenance After Induction with Imatinib In Chronic Myeloid Leukemia (CML) Patients.

ABL Mutations In Early Chronic Phase Chronic Myeloid Leukemia (CP-CML) Are Associated with a Greater Likelihood of Progression and Shorter Survival

Adult Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph + ALL) Treated at Diagnosis with Imatinib Followed by 2 nd Line TKI (Imatinib or Dasatinib) and Stem Cell Transplantation.

90 y Ibritumomab Tiuxetan as Initial Treatment for Follicular Lymphoma (ZEUS Protocol). An Italian Cooperative Study Group

Reduced-Intensity Conditioning for Allograft (RICT) after Cytoreductive Autograft (ASCT) in Relapsed/Resistant Hodgkin’s Lymphoma (HL)

Late Platelets Recovery after Autografting (ASCT) in Patients with Acute Myeloid Leukemia (AML) Is A Prognostically Favourable Factor for Long-Term Remission

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only